Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease.
about
Conventional, molecular methods and biomarkers molecules in detection of septicemiaMechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary diseaseAcute exacerbations of chronic obstructive pulmonary disease are associated with decreased CD4+ & CD8+ T cells and increased growth & differentiation factor-15 (GDF-15) in peripheral blood.The levels of serum pro-calcitonin and high-sensitivity C-reactive protein in the early diagnosis of chronic obstructive pulmonary disease during acute exacerbation.Emergency department management of acute exacerbations of chronic obstructive pulmonary disease and factors associated with hospitalization.A unique protein profile of peripheral neutrophils from COPD patients does not reflect cytokine-induced protein profiles of neutrophils in vitroAssociation of serum interleukin-27 with the exacerbation of chronic obstructive pulmonary diseaseNew approaches to sepsis: molecular diagnostics and biomarkers.Markers of exacerbation severity in chronic obstructive pulmonary diseaseMuscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I.Measurement of C-reactive protein, procalcitonin and neutrophil elastase in saliva of COPD patients and healthy controls: correlation to self-reported wellbeing parameters.Raised CRP levels mark metabolic and functional impairment in advanced COPD.Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease.Chronic obstructive pulmonary disease: clinical signs and infections.The role of airway secretions in COPD--clinical applications.Systemic inflammation in COPD: is genetic susceptibility a key factor?Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease.Acute exacerbations and respiratory failure in chronic obstructive pulmonary diseaseCardiac disease in chronic obstructive pulmonary diseaseUpdate in chronic obstructive pulmonary disease 2007.Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease.Optimizing antibiotic selection in treating COPD exacerbationsRole of macrolide therapy in chronic obstructive pulmonary disease.Defining exacerbations in chronic obstructive pulmonary disease.Neutrophil CD64 as a Marker of Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.Evaluation of plasma leptin, tumor necrosis factor-α, and prealbumin as prognostic biomarkers during clinical recovery from acute exacerbations of chronic obstructive pulmonary disease.The differences of eosinophil- and neutrophil-related inflammation in elderly allergic and non-allergic chronic obstructive pulmonary disease.Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.Effect of exposure to solid wastes in relation to employment duration on some important markers of health and disease in waste management workers of Ogun State in southwest Nigeria.Efficacy of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support.Impact of chronic obstructive pulmonary diseases on outcomes and hospital days after percutaneous coronary intervention.Delayed resolution of inflammatory response compared with clinical recovery in patients with acute exacerbations of chronic obstructive pulmonary disease.Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease.Comparison of tumor markers and inflammatory biomarkers in chronic obstructive pulmonary disease (COPD) exacerbations.Is It Time to Change the Definition of Acute Exacerbation of Chronic Obstructive Pulmornary Disease? What Do We Need to Add?Blood biomarkers as predictors of long-term mortality in COPD
P2860
Q26799362-1684C167-6C28-435F-BFA3-AE0C6E2A2312Q27000043-87F42EB3-C9ED-4392-88A2-F746714C98DAQ30371420-48A3D66E-B938-4539-A34C-E903064794FBQ33847138-9E3F2ECF-DC4F-44D8-93A1-E551C5DB05A5Q33970990-E97E104D-0DB8-46DF-9700-E22159CA6266Q34012362-337366B4-3273-40C9-AACA-3095B8DB32ADQ34297424-ED1B3BA2-8179-4A03-962A-924AC85B4E52Q34303687-6FAC7864-0125-4FCE-A3CA-76FCD88497F2Q34691221-BCFFF1D1-6638-43CD-8FEF-CFFE2D0F3E0FQ35536202-A61C76E7-A4ED-4532-921E-5A4B57D2BC26Q35672964-1E50C283-906E-42DA-A356-1D43B13DF8A3Q36148662-59CA757E-0BEC-496C-B5C9-F5A280315F28Q36379352-68A4543B-8543-49DE-9E88-EE2E8FE41EC7Q36654855-0A4BD26C-EEC5-40A0-AC5C-A1D9CD19174CQ36674113-31EA501D-8F39-411D-AB1C-19098B830E25Q36686862-041045D7-1E9F-4211-B573-8E86DBA4E21FQ37029615-591F58B6-D10D-4BF7-93FD-CB8BDD888846Q37103705-D22F6DE2-3D43-4F74-94CD-CAE51771FD8BQ37103712-ECC6B73B-0988-4E9E-AB49-508B5B166651Q37129292-A096BD8A-8A21-4EA2-ABDB-1EF55571AF85Q37153293-0BA5B0A1-A96F-419C-8CAD-E8FF98720AD6Q37167347-5175F9A7-C3ED-4451-AD95-B6E5246B66D3Q37319950-DD444921-0410-423B-BF09-92262F94BBB8Q38503383-A4A2F1E1-869C-4F51-B8F3-D396BD3FA926Q39736769-8B585D00-4DBC-41FB-80C6-F7529EE51119Q41546375-DADD9936-9CF9-4900-AD70-39B11BA8A4D8Q41958409-4F7B16DA-CBE5-474D-BAD8-D523BDBE3085Q42880991-EBE0423D-3212-4052-9834-D9DA9F1D71B4Q43252196-7ACC91F3-E6F1-48DA-B824-CF9F411EF6D4Q43359028-3DB5C72B-CEE2-45E2-B5A5-C00BC59DB5F6Q45156975-3A5CD9D5-1C3E-4686-9D5E-6BCE0CE472A9Q46463389-8E2EAB67-F5D6-49D6-A082-A9B0D3CF0679Q48235233-36B419E6-E8CD-4497-9183-77F008B70CA9Q48448565-6675B7A3-9DFE-4664-A370-C7220D0AB804Q51063268-2C58DA8D-01E7-410B-8AE5-C55E538B1D10Q55415106-4227224A-F6A2-4CA6-8A6B-085DF644F174Q58856101-2D1F26FE-2F8A-46E8-B1F5-68A9B7E66D6E
P2860
Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Value of C-reactive protein me ...... obstructive pulmonary disease.
@en
Value of C-reactive protein me ...... obstructive pulmonary disease.
@nl
type
label
Value of C-reactive protein me ...... obstructive pulmonary disease.
@en
Value of C-reactive protein me ...... obstructive pulmonary disease.
@nl
prefLabel
Value of C-reactive protein me ...... obstructive pulmonary disease.
@en
Value of C-reactive protein me ...... obstructive pulmonary disease.
@nl
P2093
P1433
P1476
Value of C-reactive protein me ...... obstructive pulmonary disease.
@en
P2093
Cunniffe J
Emmanuel FX
Sankaran R
P304
P356
10.1016/S0954-6111(98)90515-7
P577
1998-04-01T00:00:00Z